Back
Atea Pharmaceuticals, Inc. 10K Form
Sell
34
AVIR
Atea Pharmaceuticals, Inc.
Last Price:
$5.77
Seasonality Move:
-4.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AVIR News And Ratings
See the #1 stock for the next 7 days that we like better than AVIR
AVIR Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-28.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.53 |
| Price / Book: | 1.7 |
Profitability
| EPS (TTM): | -1.95230 |
|---|---|
| Net Income (TTM): | $-158.3M |
| Gross Margin: | $-416K |
| Return on Equity: | -43.85% |
| Return on Assets: | -40.51% |
Atea Pharmaceuticals, Inc. Earnings Forecast
Key Atea Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 4 years.
Atea Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AVIR |
| CUSIP: | 04683R |
| Website: | ateapharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.82 |
| Quick Ratio: | 7.59 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AVIR Technical Analysis vs Fundamental Analysis
Sell
34
Atea Pharmaceuticals, Inc. (AVIR)
is a Sell
Is Atea Pharmaceuticals, Inc. a Buy or a Sell?
-
Atea Pharmaceuticals, Inc. stock is rated a SellThe current Atea Pharmaceuticals, Inc. [AVIR] share price is $5.76. The Score for AVIR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.